Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.46 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14471274 | 0.85 | HSP90AA1 (0.46) | HSP90AA1RAB9ANPC1TP53MAPT | |
| SCHEMBL12657814 | 0.84 | MEN1 (0.49) | HSP90AA1TP53MAPTGAAPOLB | |
| SCHEMBL10171783 | 0.81 | KDM4E (0.51) | HSP90AA1MAPTGAAPOLB | |
| SCHEMBL11315740 | 0.75 | HPGD (0.50) | HSP90AA1LMNAHTTTP53MAPT | |
| SCHEMBL7745468 | 0.72 | LMNA (0.70) | LMNAHTTTP53MAPTGAA | |
| SCHEMBL11641243 | 0.72 | DRD2 (0.56) | DRD2TBXA2RGAA | |
| SCHEMBL5205919 | 0.72 | LMNA (0.47) | P2RX3LMNARAB9ANPC1HTT | |
| SCHEMBL3534743 | 0.72 | LMNA (0.63) | LMNAHTTMAPTDRD2TBXA2R | |
| SCHEMBL4253579 | 0.72 | GAA (0.65) | HTTTP53MAPTGAAPOLB | |
| SCHEMBL11400973 | 0.71 | TDP1 (0.41) | LMNARAB9ANPC1HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9551724-B2 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL, INC. (US) | 2017-01-24 | — | — | US | disclosed |
| US-9551724-B2 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL, INC. (US) | 2017-01-24 | — | — | US | disclosed |
| EP-2280281-B1 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL INC (US) | 2014-05-21 | — | — | EP | disclosed |
| US-20100204456-A1 | 5-Fluoro-Uracil Immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2010-08-12 | — | — | US | disclosed |
| US-7767794-B2 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL INC (US) | 2010-08-03 | — | — | US | disclosed |
| US-20070154972-A1 | 5-Fluoro-uracil immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2007-07-05 | — | — | US | disclosed |
| US-7205116-B2 | 5-Fluoro-uracil immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2007-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204456-A1 | 5-Fluoro-Uracil Immunoassay | UNG, DPYD, DUT | HSP90AA1 3147/4885P2RX3 3472/4885LMNA 4568/4885 |
| US-20070154972-A1 | 5-Fluoro-uracil immunoassay | UNG, DPYD, DUT | HSP90AA1 3147/4885P2RX3 3472/4885LMNA 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.